Stanley Erck is the founder of Novavax. He served as CEO during the company's development of a 90.4% effective COVID-19 vaccine.
Stanley Erck is the co-founder and former CEO of Novavax, a U.S. clinical-stage biotechnology firm. He served as CEO during the company's development of a 90.4% effective COVID-19 vaccine. In March 2021, he was elected executive chairman of Novavax, transitioning from his CEO role.
Full founder directory · Investor directory · Company funding database · Fundraising library